Site-specific Lys-63-linked Tumor Necrosis Factor Receptor-associated Factor 6 Auto-ubiquitination Is a Critical Determinant of IκB Kinase Activation*
暂无分享,去创建一个
Hao Wu | Hao Wu | B. Lamothe | B. Darnay | Arnaud Besse | Betty Lamothe | Bryant G. Darnay | Arnaud Besse | Alejandro D. Campos | William K. Webster | William K Webster | Hao Wu
[1] Sakae Tanaka,et al. RANK‐mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis , 2005, The EMBO journal.
[2] Hiroshi Takayanagi,et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.
[3] L. Cantley,et al. The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.
[4] Hao Wu,et al. Distinct molecular mechanism for initiating TRAF6 signalling , 2002, Nature.
[5] Zhijian J. Chen,et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.
[6] C. Pickart,et al. Molecular Insights into Polyubiquitin Chain Assembly Crystal Structure of the Mms2/Ubc13 Heterodimer , 2001, Cell.
[7] T. Kitamura,et al. New experimental approaches in retrovirus-mediated expression screening. , 1998, International journal of hematology.
[8] W. Xiao,et al. The TRAF6 RING finger domain mediates physical interaction with Ubc13 , 2004, FEBS letters.
[9] V. Dixit,et al. RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.
[10] Zhijian J. Chen,et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.
[11] S. Nishikawa,et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Karin,et al. Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.
[13] Honglin Zhou,et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.
[14] Y. Xiong,et al. A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α* , 2003, Journal of Biological Chemistry.
[15] B. Aggarwal,et al. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. , 1999, The Journal of biological chemistry.
[16] I. Lax,et al. FRS2α attenuates FGF receptor signaling by Grb2- mediated recruitment of the ubiquitin ligase Cbl , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Morony,et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.
[18] Hao Wu,et al. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[19] M. Walsh,et al. The role of TRAF6 in signal transduction and the immune response. , 2004, Microbes and infection.
[20] Zhijian J. Chen,et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.
[21] M. Talpaz,et al. TWEAK Mediates Signal Transduction and Differentiation of RAW264.7 Cells in the Absence of Fn14/TweakR , 2003, Journal of Biological Chemistry.
[22] Sakae Tanaka,et al. Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[23] S. Srinivasula,et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.
[24] Gabriel Pineda,et al. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.
[25] Y. Kadono,et al. Strength of TRAF6 signalling determines osteoclastogenesis , 2005, EMBO reports.
[26] C. Pickart,et al. Ubiquitin: structures, functions, mechanisms. , 2004, Biochimica et biophysica acta.
[27] F. Martinon,et al. Inflammatory Diseases: Is Ubiquitinated NEMO at the Hub? , 2004, Current Biology.
[28] Joseph E. Coleman,et al. Crystal structure of the RAG1 dimerization domain reveals multiple zinc-binding motifs including a novel zinc binuclear cluster , 1997, Nature Structural Biology.
[29] Zhijian J. Chen. Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.
[30] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[31] Young Chul Park,et al. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. , 2002, Journal of cell science.
[32] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[33] Min Gao,et al. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. , 2005, Molecular cell.
[34] Manuel C. Peitsch,et al. SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..
[35] B. Aggarwal,et al. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. , 1998, The Journal of biological chemistry.